2). (Hamblin, 1970 , Koch-Weser, & Seller, 1971 ).
In the present series of 103 haemorrhagic episodes during five years of outpatient treatment, more than one third of the haemorrhages appear to have occurred directly as a result of administration of drugs which are known to interfere in some way with warfarin metabolism, or as a result of medical conditions known to cause haemorrhage when warfarin is given. No simple explanation for the remaining two thirds of the haemorrhages was obtained, but a disturbing new factor became apparent when the time of each haemorrhagic episode was examined in relation to the duration of oral anticoagulant therapy. Nearly one third of the episodes occurred during the first month, and 46% of the episodes occurred during the first two months.
It is therefore suggested that when a patient is started on oral anticoagulant therapy (with or without concurrent heparin therapy during the first four days), warfarin should be given at the rate of 10-15 mg per day, depending on the patient's weight. An initial loading dose should be avoided, since this produces marked reduction in plasma Factor VII with prolongation of the prothrombin time within 24-48 hours, with only minimal effects on plasma Factors II, IX, and X, and hence with only minimal effect on the activated partial thromboplastin time and intrinsic coagulation (Deykin, 1970 
